| Name of the Product/Stage | CAS No |
| Abacavir Sulfate | 188062-50-2 |
| Name of the Product/Stage | Atazanavir Sulfate |
| Chemical Name | (1S,4R)-4-[2-Amino-6-(Cycloprpylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol sulfate |
| CAS No. | 188062-50-2 |
| API /INT | API |
| Pharmacopeial compliance | IP,USP, and Ph.Eur |
| Name of the Product/Stage | CAS No |
| Atazanavir Sulfate | 198904-31-3 |
| Name of the Product/Stage | Atazanavir Sulfate |
| Chemical Name | methyl N-[(1S)-1-{[(2S,3S)-3-hydroxy-4-[(2S)-2-[(methoxycarbonyl)amino]-3,3-dimethyl-N'-{[4-(pyridin-2-yl)phenyl]methyl}butanehydrazido]-1-phenylbutan-2-yl]carbamoyl}-2,2-dimethylpropyl]carbamate |
| CAS No. | 198904-31-3 |
| API /INT | API |
| Pharmacopeial compliance | IP, and Ph.Eur |
| Name of the Product/Stage | CAS No |
| Darunavir Ethanolate | 635728-49-3 |
| Name of the Product/Stage | Darunavir Ethanolate |
| Chemical Name | (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl N-[(2S,3R)-3-hydroxy-4-[N-(2-methylpropyl)4-aminobenzenesulfonamido]-1-phenylbutan-2-yl]carbamate; ethano |
| CAS No. | 635728-49-3 |
| API /INT | API |
| Pharmacopeial compliance | IHS & IP |
| Name of the Product/Stage | CAS No |
| Ritonavir | 155213-67-5 |
| Name of the Product/Stage | Ritonavir |
| Chemical Name | (5s,8s,10s,11s)-10-hydroxy-2-methyl-5-(1-methylethyl)-1-[2-(1-methylethyl)-4-thiazolyl]-3,6-dioxo-8,11-bis(phenyl methyl)-2,4,7,12-tetraazatridecan-13-oic acid 5-thiozolylmethyl ester (or) RTV-4 |
| CAS No. | 155213-67-5 |
| API /INT | API |
| Pharmacopeial compliance | IP,USP and Ph.Eur |
| Name of the Product/Stage | CAS No |
| Lopinavir | 192725-17-0 |
| Name of the Product/Stage | Lopinavir |
| Chemical Name | 2S[1s-[1r*(r*),3r*,4r*]-n-[4[(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]-tetrahydro-α-(1-methylethyl)-2-oxo-1(2h)-pyrimidineacetamide. (or) LPV |
| CAS No. | 192725-17-0 |
| API /INT | API |
| Pharmacopeial compliance | IP,USP and Ph.Eur |
| Name of the Product/Stage | CAS No |
| Gabapentin | 1436-60-8 |
| Name of the Product/Stage | Gabapentin |
| Chemical Name | Cyclohexaneacetic acid, 1-(aminomethyl)- |
| CAS No. | 1436-60-8 |
| API /INT | API |
| Pharmacopeial compliance | USP&IP |
| Name of the Product/Stage | CAS No |
| Molunapiravir | 2349386-89-4 |
| Name of the Product/Stage | Molunapiravir |
| Chemical Name | ((2R,3S,4R,5R)-3,4-Dihydroxy-5-((4Z)-4-(hydroxyimino)-2-oxo-3,4- dihydropyrimidin-1(2H)-yl)oxolan-2-yl)methyl 2-methylpropanoate |
| CAS No. | 2349386-89-4 |
| API /INT | API |
| Pharmacopeial compliance | IHS |
| Name of the Product/Stage | CAS No |
| Lamivudine | 134678-17-4 |
| Name of the Product/Stage | Lamivudine |
| Chemical Name | Cyclohexaneacetic acid, 1-(aminomethyl)- |
| CAS No. | 134678-17-4 |
| API /INT | API |
| Pharmacopeial compliance | USP |
| Name of the Product/Stage | CAS No |
| Dolutegravir Sodium | 1051375-16-6 |
| Name of the Product/Stage | Dolutegravir Sodium |
| Chemical Name | (4R,12aS)-N-(2,4-Difluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide |
| CAS No. | 1051375-16-6 |
| API /INT | API |
| Pharmacopeial compliance | HIS |
| Name of the Product/Stage | CAS No |
| Ticagrelor | 274693-27-5 |
| Name of the Product/Stage | Ticagrelor |
| Chemical Name | (1S,2S,3R,5S)-3-[7-{[(1R,2S)-2-(3,4-Difluorophenyl) cyclopropyl]amino}-5-(propylthio)-3H-[1,2,3]-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy) cyclopentane-1,2-diol |
| CAS No. | 274693-27-5 |
| API /INT | API |
| Pharmacopeial compliance | USP/IHS |
| Name of the Product/Stage | CAS No |
| Lisinopril | 83915-83-7 |
| Name of the Product/Stage | Lisinopril |
| Chemical Name | (2S)-1-, pyrrolidine-2-carboxylic acid |
| CAS No. | 83915-83-7 |
| API /INT | API |
| Pharmacopeial compliance | USP/IHS |
| Name of the Product/Stage | CAS No |
| Lamivudine | 134678-17-4 |
| Name of the Product/Stage | Lamivudine |
| Chemical Name | (2R-cis) 4-Amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone |
| CAS No. | 134678-17-4 |
| API /INT | API |
| Pharmacopeial compliance | USP |
| Name of the Product/Stage | CAS No |
| Citicoline | 987-78-0 |
| Name of the Product/Stage | Citicoline |
| Chemical Name | Cytidine 5'-(trihydrogen diphosphate), mono[2-(trimetylammonio)etyl] ester, hydroxide, inner salt |
| CAS No. | 987-78-0 |
| API /INT | API |
| Pharmacopeial compliance | IP/USP |
| Name of the Product/Stage | CAS No |
| Tenofovir Disoproxil Fumarate | 202138-50-9 |
| Name of the Product/Stage | Tenofovir Disoproxil Fumarate |
| Chemical Name | Bis(1-methyl-ethyl)ester-(R)-5-[[2-(6-Amino-9H-purin-9-yl)-1-methylethoxy]methyl]-2,4,6,8-tetraoxa-5-phosphanonanedioic acid 5-oxide (E)-2-butenedioate |
| CAS No. | 202138-50-9 |
| API /INT | API |
| Pharmacopeial compliance | USP |
| Name of the Product/Stage | CAS No |
| Tenofovir alafenamide | 379270-37-8 |
| Name of the Product/Stage | Tenofovir alafenamide |
| Chemical Name | l-alanine, N-[(S)-[[(1R)-2-(6-Amino-9H-purin-9-yl)-1methylethoxy]methyl]phenoxyphosphinyl]-, 1-methylethyl ester, (2E)-2-butenedioate |
| CAS No. | 379270-37-8 |
| API /INT | API |
| Pharmacopeial compliance | USP |
| Name of the Product/Stage | CAS No |
| Sitagliptin Phosphate Monohydrate | 654671-77-9 |
| Name of the Product/Stage | Sitagliptin Phosphate Monohydrate |
| Chemical Name | (3R)-3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl) butan-1-one;phosphoric acid;hydrate |
| CAS No. | 654671-77-9 |
| API /INT | API |
| Pharmacopeial compliance | Ph-Eur |
| Name of the Product/Stage | CAS No |
| Sitagliptin Phosphate | 654671-78-0 |
| Name of the Product/Stage | Sitagliptin Phosphate |
| Chemical Name | (3R)-3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl) butan-1-one;phosphoric acid |
| CAS No. | 654671-78-0 |
| API /INT | API |
| Pharmacopeial compliance | Ph.Eur/USP |
| Name of the Product/Stage | CAS No |
| Abacavir Sulfate (AFC) | 171887-04-0 |
| Name of the Product/Stage | Abacavir Sulfate (AFC) |
| Chemical Name | (1S, 4R)-4-[(2-amino-6-chloro-5-formamido-4-pyrimidinyl) amino]-2-cyclopentene-1-methanol |
| CAS No. | 171887-04-0 |
| API /INT | Intermediate |
| Pharmacopeial compliance | IHS |
| Name of the Product/Stage | CAS No |
| Atzanavir t-BOC Hydrazine (TBH-2) | 198904-85-7 |
| Name of the Product/Stage | Atzanavir t-BOC Hydrazine (TBH-2) |
| Chemical Name | 4-(-2-pyridyl) benzaldehyde-t-Boc hydrazine |
| CAS No. | 198904-85-7 |
| API /INT | Intermediate |
| Pharmacopeial compliance | IHS |
| Name of the Product/Stage | CAS No |
| Atzanavir (2R,3S) BOC EPOXIDE (APR-3) | 98760-08-8 |
| Name of the Product/Stage | Atzanavir (2R,3S) BOC EPOXIDE (APR-3) |
| Chemical Name | (2R,3S)-3-(Tert-Butoxycarbonyl)Amino-1,2-Epoxy-4-phenylbutane |
| CAS No. | 98760-08-8 |
| API /INT | Intermediate |
| Pharmacopeial compliance | IHS |
| Name of the Product/Stage | CAS No |
| Darunavir Ethanolate Nitro complex (DAS) | 192725-55-6 |
| Name of the Product/Stage | Darunavir Ethanolate Nitro complex (DAS) |
| Chemical Name | (3R,-3aS,6aR)-Hexhydrofuro[2,3-b]furan-3-yl-4-nitrophenyl carbonate |
| CAS No. | 192725-55-6 |
| API /INT | Intermediate |
| Pharmacopeial compliance | IHS |
| Name of the Product/Stage | CAS No |
| Darunavir Ethanolate Bisfroanol (BIS-4) | 156928-09-5 |
| Name of the Product/Stage | Darunavir Ethanolate Bisfroanol (BIS-4) |
| Chemical Name | (3R,3as,6as) – Hexahydrofluro [2,3-B] furan-3-OL |
| CAS No. | 156928-09-5 |
| API /INT | Intermediate |
| Pharmacopeial compliance | IHS |
| Name of the Product/Stage | CAS No |
| Chloro Ketone ZOE-3 | 128018-43-9 |
| Name of the Product/Stage | Chloro Ketone ZOE-3 |
| Chemical Name | Benzyl [(2S,3S)-4-Chloro-3-Hydroxy-1-Phenylbutan-2-YL] Carbonate |
| CAS No. | 128018-43-9 |
| API /INT | Intermediate |
| Pharmacopeial compliance | HIS |
| Name of the Product/Stage | CAS No |
| Darunavir Ethanolate (n-1 stage) (BOD-6) | 169280-56-2 |
| Name of the Product/Stage | Darunavir Ethanolate (n-1 stage) (BOD-6) |
| Chemical Name | 4-Amino-N-[(2R,3S)-3-Amino-2-Hydroxy-4-Phenyl Butyl]-N-isobutylbenzene-1-Sulfonamide |
| CAS No. | 169280-56-2 |
| API /INT | Intermediate |
| Pharmacopeial compliance | HIS |
| Name of the Product/Stage | CAS No |
| Lopinavir (LPR-1) | 192725-17-0 |
| Name of the Product/Stage | Lopinavir (LPR-1) |
| Chemical Name | (2S,3S,5S)-2-(2,6-Dimethyl phenoxy acetyl) Amino-3-Hydroxy-5-(2S-(1-Tetrahydropyrmid-2-onyl)-3-methyl butanoyl) Amino-1,6-Diphenyl hexane |
| CAS No. | 192725-17-0 |
| API /INT | Intermediate |
| Pharmacopeial compliance | HIS |
| Name of the Product/Stage | CAS No |
| Lopinavir THP-CDI | 192725-17-0 |
| Name of the Product/Stage | Lopinavir THP-CDI |
| Chemical Name | (2S,3S,5S)-2-Amino-3-Hydroxy-5-(1-Tetra Hydro Pyrmid-2-Onyl)-3-Methyl Butanoyl) Amino-1,6-Diphenyl Hexane-s-Pyro Glutamate |
| CAS No. | 192725-17-0 |
| API /INT | Intermediate |
| Pharmacopeial compliance | IHS |
| Name of the Product/Stage | CAS No |
| Zofenopril Calcium | 105107-84-4 |
| Name of the Product/Stage | Zofenopril Calcium |
| Chemical Name | Cis-4-Phenylthio-l-Proline Hydrochloride |
| CAS No. | 105107-84-4 |
| API /INT | Intermediate |
| Pharmacopeial compliance | HIS |
| Name of the Product/Stage | CAS No |
| Febantal | 5443-33-4 |
| Name of the Product/Stage | Febantal |
| Chemical Name | 2-Nitro-5-Chloro Acetanilide(DM-1) |
| CAS No. | 5443-33-4 |
| API /INT | Intermediate |
| Pharmacopeial compliance | HIS |
| Name of the Product/Stage | CAS No |
| Dolutegravir | 1646862-09-0 |
| Name of the Product/Stage | Dolutegravir |
| Chemical Name | Methyl 5-[(2,4-Difluorobenzyl)Carbamoyl]-3-Methoxy-4-Oxo-1-(2-oxoethyl)-1,4-Dihydropyridine-2-Carboxylate (or) DTS-3 |
| CAS No. | 1646862-09-0 |
| API /INT | Intermediate |
| Pharmacopeial compliance | HIS |
| Name of the Product/Stage | CAS No |
| Dolutegravir | 1335210-23-5 |
| Name of the Product/Stage | Dolutegravir |
| Chemical Name | 1-(2,2-dimethoxyethyl)-5-methoxy-6-(methoxycarbonyl) -4-oxo-1,4-dihydropyridine-3-carboxylic acid. Chemical Formula: C13H17NO8 Molecular Weight: 315.28 |
| CAS No. | 1335210-23-5 |
| API /INT | Intermediate |
| Pharmacopeial compliance | HIS |
| Name of the Product/Stage | CAS No |
| Dolutegravir | 1335210-35-9 |
| Name of the Product/Stage | Dolutegravir |
| Chemical Name | (4R,12aS)-N-(2,4-difluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide. Chemical Formula: C20H19F2N3O5 Molecular Weight: 419.38 |
| CAS No. | 1335210-35-9 |
| API /INT | Intermediate |
| Pharmacopeial compliance | HIS |
| Name of the Product/Stage | CAS No |
| Nitro Complex | 5070-13-3 |
| Name of the Product/Stage | Nitro Complex |
| Chemical Name | 3R,3A S,6AR-Hexhydro Furo-(2,3-B)-Furan 3-YL-4-Nitrophenyl Carbonate (DAI-7) |
| CAS No. | 5070-13-3 |
| API /INT | Intermediate |
| Pharmacopeial compliance | HIS |
| Name of the Product/Stage | CAS No |
| MCPP HCL | 65369-76-8 |
| Name of the Product/Stage | MCPP HCL |
| Chemical Name | 1-(3-chloro Phenyl) Piperazine Hydrochloride |
| CAS No. | 65369-76-8 |
| API /INT | Intermediate |
| Pharmacopeial compliance | IHS |
| Name of the Product/Stage | CAS No |
| Amino Alcohol HCL AAN | 168960-19-8 |
| Name of the Product/Stage | Amino Alcohol HCL AAN |
| Chemical Name | (1S,4R)-4-Amino-2-Cyclopentene-1-Methanol Hydrochloride |
| CAS No. | 168960-19-8 |
| API /INT | Intermediate |
| Pharmacopeial compliance | IHS |
| Name of the Product/Stage | CAS No |
| PSD | 274-07-7 |
| Name of the Product/Stage | PSD |
| Chemical Name | Piperidine Sulfamoyl Dimer |
| CAS No. | 274-07-7 |
| API /INT | Intermediate |
| Pharmacopeial compliance | IHS |
| Name of the Product/Stage | CAS No |
| Ritonavir (BDH) | 183388-64-9 |
| Name of the Product/Stage | Ritonavir (BDH) |
| Chemical Name | (2S,3S,5S)-2-amino-3-hydroxy-5-(tert-butyloxycarbonylamino)-1,6-diphenyl hexane succinin acid salt |
| CAS No. | 183388-64-9 |
| API /INT | Ritonavir Intermediate |
| Pharmacopeial compliance | HIS |
| Name of the Product/Stage | CAS No |
| NCT | 144163-97-3 |
| Name of the Product/Stage | NCT |
| Chemical Name | Carbonic Acid, 4-Nitrophenyl-5-thiazolyl methyl ester(NCT) |
| CAS No. | 144163-97-3 |
| API /INT | Ritonavir Intermediate |
| Pharmacopeial compliance | HIS |
| Name of the Product/Stage | CAS No |
| MTV-3 | 201409-23-6 |
| Name of the Product/Stage | MTV-3 |
| Chemical Name | N-((N-Methyl-N-((2-Isopropyl-4-Thiazolyl)Methyl) Amino)Carbonyl)-L-Valine,Lithium Salt |
| CAS No. | 201409-23-6 |
| API /INT | Ritonavir Intermediate |
| Pharmacopeial compliance | HIS |
| Name of the Product/Stage | CAS No |
| Abacavir Sulfate | 198904-31-3 |
| Name of the Product/Stage | Atazanavir Sulfate |
| Chemical Name | methyl N-[(1S)-1-{[(2S,3S)-3-hydroxy-4-[(2S)-2-[(methoxycarbonyl)amino]-3,3-dimethyl-N'-{[4-(pyridin-2-yl)phenyl]methyl}butanehydrazido]-1-phenylbutan-2-yl]carbamoyl}-2,2-dimethylpropyl]carbamate |
| CAS No. | 198904-31-3 |
| API /INT | API |
| Pharmacopeial compliance | IP, and Ph.Eur |
| Name of the Product/Stage | CAS No |
| Abacavir Sulfate | 198904-31-3 |
| Name of the Product/Stage | Atazanavir Sulfate |
| Chemical Name | methyl N-[(1S)-1-{[(2S,3S)-3-hydroxy-4-[(2S)-2-[(methoxycarbonyl)amino]-3,3-dimethyl-N'-{[4-(pyridin-2-yl)phenyl]methyl}butanehydrazido]-1-phenylbutan-2-yl]carbamoyl}-2,2-dimethylpropyl]carbamate |
| CAS No. | 198904-31-3 |
| API /INT | API |
| Pharmacopeial compliance | IP, and Ph.Eur |